Thermo Fisher Scientific (NYSE:TMO) introduces Amplitude Solution, a high-throughput molecular testing system designed to process up to 6,000 COVID-19 samples per day.
The system combines its Applied Biosystems QuantStudio 7 Flex Real-Time PCR instruments with Tecan Group’s liquid handling gear to analyze samples with its Applied Biosystems TaqPath COVID-19 Combo Kit, a multiplex diagnostic test that detects nucleic acid from the SARS-CoV-2 virus.
TMO plans to file global applications for emergency use authorization during the pandemic.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.